CMANY
BMY icon

Capital Management Associates (New York)’s Bristol-Myers Squibb BMY Stock Holding History

Capital Management Associates (New York)’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-3,775
Closed -$210K – 74
2020
Q1 		$210K Buy
+3,775
New +$231K 0.38% 70
2018
Q4 		– Sell
-3,650
Closed -$227K – 105
2018
Q3 		$227K Hold
3,650
– – 0.28% 126
2018
Q2 		$202K Buy
+3,650
New +$197K 0.25% 134
2018
Q1 		– Sell
-3,650
Closed -$224K – 124
2017
Q4 		$224K Sell
3,650
-600
-14% -$37.5K 0.32% 114
2017
Q3 		$271K Hold
4,250
– – 0.39% 111
2017
Q2 		$237K Hold
4,250
– – 0.36% 110
2017
Q1 		$231K Sell
4,250
-500
-11% -$27.4K 0.35% 117
2016
Q4 		$278K Hold
4,750
– – 0.44% 103
2016
Q3 		$256K Buy
4,750
+900
+23% +$57.8K 0.4% 108
2016
Q2 		$283K Hold
3,850
– – 0.48% 89
2016
Q1 		$246K Hold
3,850
– – 0.45% 95
2015
Q4 		$265K Sell
3,850
-100
-3% -$6.61K 0.39% 111
2015
Q3 		$234K Sell
3,950
-300
-7% -$19K 0.36% 120
2015
Q2 		$283K Sell
4,250
-100
-2% -$6.59K 0.37% 122
2015
Q1 		$281K Sell
4,350
-100
-2% -$6.26K 0.37% 115
2014
Q4 		$263K Sell
4,450
-1,250
-22% -$70.5K 0.39% 113
2014
Q3 		$292K Sell
5,700
-200
-3% -$9.99K 0.44% 114
2014
Q2 		$286K Sell
5,900
-300
-5% -$14.8K 0.42% 115
2014
Q1 		$322K Sell
6,200
-100
-2% -$5.32K 0.47% 111
2013
Q4 		$335K Sell
6,300
-400
-6% -$20.4K 0.49% 100
2013
Q3 		$310K Sell
6,700
-600
-8% -$26.3K 0.48% 100
2013
Q2 		$326K Buy
+7,300
New +$317K 0.53% 94

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Capital Management Associates (New York)'s BMY Position: Q2 2020 in Review

Capital Management Associates (New York) sold out of Bristol-Myers Squibb (BMY) in Q2 2020, closing a stake of 3,775 shares — an estimated $210K sold.

Capital Management Associates (New York) first reported a position in BMY in Q2 2013 and held it in 22 quarters. The position peaked at $335K in Q4 2013. 2,190 funds tracked by Wall St. Rank hold BMY as of Q2 2020.

  • Capital Management Associates (New York) reported no remaining Bristol-Myers Squibb position as of Q2 2020 after selling out during the quarter.
  • Capital Management Associates (New York) sold 3,775 Bristol-Myers Squibb shares in Q2 2020, an estimated $210K.
  • Capital Management Associates (New York) first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 22 quarters.
  • Capital Management Associates (New York)'s Bristol-Myers Squibb position peaked at $335K in Q4 2013.
  • 2,190 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2020.

Based on Capital Management Associates (New York)'s 13F filing for Q2 2020, filed 5 Aug 2020.